ミズホメディー
4595
東証スタンダード
医薬品
ミズホメディーの決算推移
損益計算書
(単位:百万円)
2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|
売上高 | 4,082 | 4,961 | 5,624 | 6,423 | 6,427 | 4,205 | 13,137 | 17,581 | 10,989 |
売上原価 | 1,422 | 1,771 | 1,964 | 2,098 | 2,087 | 1,444 | 3,234 | 3,481 | 2,915 |
売上総利益 | 2,659 | 3,190 | 3,659 | 4,325 | 4,340 | 2,760 | 9,903 | 14,100 | 8,074 |
販管費 | 2,272 | 2,661 | 2,808 | 3,105 | 3,228 | 2,342 | 2,953 | 2,995 | 2,922 |
営業利益 | 388 | 529 | 850 | 1,220 | 1,111 | 416 | 6,698 | 11,104 | 5,151 |
営業外収益 | 2 | 2 | 2 | 2 | 2 | 1 | 4 | 16 | 140 |
営業外費用 | 19 | 7 | 1 | 11 | 2 | 2 | 2 | 50 | N/A |
経常利益 | 371 | 524 | 851 | 1,211 | 1,111 | 415 | 6,700 | 11,070 | 5,292 |
特別利益 | N/A | N/A | N/A | N/A | 59 | N/A | 124 | N/A | N/A |
特別損失 | 1 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
当期純利益 | 257 | 395 | 660 | 919 | 874 | 306 | 4,816 | 7,838 | 3,774 |
貸借対照表
(単位:百万円)
2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
---|---|---|---|---|---|---|---|---|---|
資産 | 3,490 | 4,041 | 4,377 | 5,582 | 6,366 | 6,051 | 12,192 | 19,102 | 18,948 |
流動資産 | 2,408 | 2,917 | 3,226 | 3,760 | 3,852 | 3,646 | 9,660 | 16,500 | 16,289 |
現金及び預金 | 41 | 75 | 265 | 235 | 217 | 54 | 4,326 | 8,702 | 10,134 |
売上債権 | 1,467 | 2,033 | 1,726 | 1,798 | 2,097 | 1,885 | 3,413 | 5,455 | 3,755 |
棚卸資産 | 868 | 746 | 785 | 1,151 | 1,141 | 1,455 | 1,265 | 1,267 | 1,596 |
固定資産 | 1,081 | 1,124 | 1,151 | 1,822 | 2,513 | 2,405 | 2,532 | 2,601 | 2,658 |
負債 | 1,900 | 2,145 | 1,940 | 2,427 | 2,612 | 2,268 | 4,164 | 4,819 | 3,272 |
流動負債 | 1,052 | 1,329 | 1,162 | 1,703 | 1,343 | 1,124 | 3,335 | 3,921 | 2,279 |
仕入債務 | 389 | 341 | 271 | 360 | 239 | 214 | 352 | 524 | 351 |
固定負債 | 848 | 816 | 777 | 723 | 1,269 | 1,144 | 828 | 897 | 992 |
純資産 | 1,589 | 1,896 | 2,437 | 3,155 | 3,753 | 3,783 | 8,028 | 14,282 | 15,675 |
利益剰余金 | 850 | 1,157 | 1,698 | 2,417 | 3,015 | 3,045 | 7,291 | 13,545 | 14,938 |
自己株式 | N/A | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -3 |